180 related articles for article (PubMed ID: 38487536)
21. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
22. Blocking the hedgehog pathway inhibits hepatoblastoma growth.
Eichenmüller M; Gruner I; Hagl B; Häberle B; Müller-Höcker J; von Schweinitz D; Kappler R
Hepatology; 2009 Feb; 49(2):482-90. PubMed ID: 19177589
[TBL] [Abstract][Full Text] [Related]
23. Hepatoblastomas exhibit marked
Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
[TBL] [Abstract][Full Text] [Related]
24. CREB1-driven CXCR4
Chen J; Bai Y; Xue K; Li Z; Zhu Z; Li Q; Yu C; Li B; Shen S; Qiao P; Li C; Luo Y; Qiao H; Dang E; Yin W; Gudjonsson JE; Wang G; Shao S
Nat Commun; 2023 Sep; 14(1):5894. PubMed ID: 37736772
[TBL] [Abstract][Full Text] [Related]
25. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
26. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
[TBL] [Abstract][Full Text] [Related]
28. Involvement of CXCL12/CXCR4 axis in colorectal cancer: a mini-review.
Bocchi M; de Sousa Pereira N; de Oliveira KB; Amarante MK
Mol Biol Rep; 2023 Jul; 50(7):6233-6239. PubMed ID: 37219666
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
[TBL] [Abstract][Full Text] [Related]
30. USP7 promotes hepatoblastoma progression through activation of PI3K/AKT signaling pathway.
Ye M; He J; Zhang J; Liu B; Liu X; Xie L; Wei M; Dong R; Li K; Ma D; Dong K
Cancer Biomark; 2021; 31(2):107-117. PubMed ID: 33780361
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
32. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
[TBL] [Abstract][Full Text] [Related]
33. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids.
Song H; Bucher S; Rosenberg K; Tsui M; Burhan D; Hoffman D; Cho SJ; Rangaswami A; Breese M; Leung S; Ventura MVP; Sweet-Cordero EA; Huang FW; Nijagal A; Wang B
Nat Commun; 2022 Aug; 13(1):4878. PubMed ID: 36008377
[TBL] [Abstract][Full Text] [Related]
34. Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study.
Litten JB; Chen TT; Schultz R; Herman K; Comstock J; Schiffman J; Tomlinson GE; Rakheja D
Pediatr Dev Pathol; 2011; 14(5):378-83. PubMed ID: 21639801
[TBL] [Abstract][Full Text] [Related]
35. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis.
Fang H; Huang Y; Luo Y; Tang J; Yu M; Zhang Y; Zhong M
Cell Immunol; 2022 Jan; 371():104458. PubMed ID: 34847407
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
Hsiao CC; Kao YH; Huang SC; Chuang JH
Pediatr Blood Cancer; 2013 Feb; 60(2):248-53. PubMed ID: 22648929
[TBL] [Abstract][Full Text] [Related]
37. Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma.
Liu BH; Zhang BB; Liu XQ; Zheng S; Dong KR; Dong R
Cell Physiol Biochem; 2018; 45(2):706-719. PubMed ID: 29414822
[TBL] [Abstract][Full Text] [Related]
38. Tumors exploit CXCR4
Peng Z; Liu C; Victor AR; Cao DY; Veiras LC; Bernstein EA; Khan Z; Giani JF; Cui X; Bernstein KE; Okwan-Duodu D
Oncoimmunology; 2021 Jan; 10(1):1870811. PubMed ID: 33537175
[TBL] [Abstract][Full Text] [Related]
39. Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma.
Wang W; Zhang N; Chen L; Zhao X; Shan Y; Yang F; Wang B; Gao H; Xu M; Tang P; Qin S; Gu S
Gene; 2024 Mar; 897():147991. PubMed ID: 37972697
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow.
Petty JM; Lenox CC; Weiss DJ; Poynter ME; Suratt BT
J Immunol; 2009 Jan; 182(1):604-12. PubMed ID: 19109194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
